Review
Copyright ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Mar 26, 2018; 10(3): 23-33
Published online Mar 26, 2018. doi: 10.4252/wjsc.v10.i3.23
Physiologically based microenvironment for in vitro neural differentiation of adipose-derived stem cells
Adriana Carol Eleonora Graziano, Rosanna Avola, Vincenzo Perciavalle, Ferdinando Nicoletti, Gianluca Cicala, Marinella Coco, Venera Cardile
Adriana Carol Eleonora Graziano, Rosanna Avola, Vincenzo Perciavalle, Marinella Coco, Venera Cardile, Department of Biomedical and Biotechnological Sciences, Section of Physiology, University of Catania, Catania 95123, Italy
Ferdinando Nicoletti, Department of Biomedical and Biotechnological Sciences, Section of Pathology and Oncology, University of Catania, Catania 95123, Italy
Gianluca Cicala, Department of Civil Engineering and Architecture, University of Catania, Catania 95125, Italy
ORCID number: Adriana Carol Eleonora Graziano (0000-0003-1652-9577); Rosanna Avola (0000-0002-3094-2416); Vincenzo Perciavalle (0000-0003-0614-2969); Ferdinando Nicoletti (0000-0002-4570-8462); Gianluca Cicala (0000-0002-4680-152X); Marinella Coco (0000-0002-1797-2717); Venera Cardile (0000-0001-9902-3736).
Author contributions: All authors had full access to all the data in the study and take responsibility for the integrity of the data; Graziano ACE and Cardile V contributed to the study concept and design; Graziano ACE, Avola R and Coco M contributed to the acquisition of data; Graziano ACE, Avola R, Coco M and Cicala G contributed to the analysis and interpretation of data; Graziano ACE and Cardile V contributed to the drafting of the manuscript; Perciavalle V, Nicoletti F and Cardile V contributed to the critical revision of the manuscript for important intellectual content; all the authors have given final approval of the version to be published and agree to be accountable for all aspects of the work.
Supported by University of Catania, Italy, FIR, No. 21040104, UPB: 20722142002; 20130143007 (partially).
Conflict-of-interest statement: All authors declare no potential conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Adriana Carol Eleonora Graziano, PhD, PharmD, Research Fellow, Department of Biomedical and Biotechnological Sciences, Section of Physiology, University of Catania, Via Santa Sofia 97, Catania 95123, Italy. acegraz@unict.it
Telephone: +39-09-54781324
Received: February 19, 2018
Peer-review started: February 19, 2018
First decision: March 13, 2018
Revised: March 20, 2018
Accepted: March 21, 2018
Article in press: March 21, 2018
Published online: March 26, 2018

Abstract

The limited capacity of nervous system to promote a spontaneous regeneration and the high rate of neurodegenerative diseases appearance are keys factors that stimulate researches both for defining the molecular mechanisms of pathophysiology and for evaluating putative strategies to induce neural tissue regeneration. In this latter aspect, the application of stem cells seems to be a promising approach, even if the control of their differentiation and the maintaining of a safe state of proliferation should be troubled. Here, we focus on adipose tissue-derived stem cells and we seek out the recent advances on the promotion of their neural differentiation, performing a critical integration of the basic biology and physiology of adipose tissue-derived stem cells with the functional modifications that the biophysical, biomechanical and biochemical microenvironment induces to cell phenotype. The pre-clinical studies showed that the neural differentiation by cell stimulation with growth factors benefits from the integration with biomaterials and biophysical interaction like microgravity. All these elements have been reported as furnisher of microenvironments with desirable biological, physical and mechanical properties. A critical review of current knowledge is here proposed, underscoring that a real advance toward a stable, safe and controllable adipose stem cells clinical application will derive from a synergic multidisciplinary approach that involves material engineer, basic cell biology, cell and tissue physiology.

Key Words: Adipose stem cells, Biomaterials, Neurodegeneration, Neural differentiation, Physiological microenvironment

Core tip: Adipose-derived stem cells are easily accessible from liposuction, obtained in large quantity and cultured for several months with low levels of senescence. Moreover, they could be induced toward a neural phenotype in vitro. The preclinical studies show that microenvironment has a predominant role. Our objective is to consolidate the current literature to better delineate the functional response of adipose-derived stem cells to biochemical, biophysical or dimensional stimuli. Specifically, chemicals - like drugs and growth factors-biomaterials and microgravity are here discussed as both single and co-applied parameters for inducing a neural lineage.


Citation: Graziano ACE, Avola R, Perciavalle V, Nicoletti F, Cicala G, Coco M, Cardile V. Physiologically based microenvironment for in vitro neural differentiation of adipose-derived stem cells. World J Stem Cells 2018; 10(3): 23-33
INTRODUCTION

The majority of neurological diseases are characterized by primary or secondary neurodegeneration with the concomitance of different degree of inflammation[1,2]. Parkinson disease[3,4], multiple sclerosis[5], traumatic injury[6] or lysosomal storage disease with neurological symptoms like Krabbe disease[7] represent conditions in which the neural cells disappearance turn into decline of patient quality of life. Therapeutic approaches are mostly symptomatic and not restorative.

Due to the skills to immunomodulation, to support the brain parenchyma and to transdifferentiate, stem cells (SC) are under evaluation in preclinical tests for the promotion of neural regeneration.

Among the different sources of SC, the adipose stem cells (ASCs) are becoming more and more popular and attract the researchers’ interest because they are easily accessible from subcutaneous liposuction, obtained in large quantity[8], cultured for several months in vitro with low levels of senescence[9,10] and applicable without ethical and political issues[11]. Moreover, ASCs have been shown to possess self-renewal property and multipotential differentiation toward adipocytes[12], chondrocytes[13,14], osteoblasts[15], myocytes[16], neurocytes[17], and other cell types[18], including neurons[19] and neural cells[20]. All these hallmarks give to ASCs potential application in regenerative medicine and clinical studies[21,22]. As regard the transdifferentiating potential of ASCs into neural cells, the transduction properties need to be further characterized. Longtime, the stimulation of ASCs by growth factors-enriched media has been the most applied procedure to induce a specific cell lineage[23], but recently it has been enlightened that the conventional two-dimensional systems do not mimic the cellular connections and the space distribution that occur in vivo[24,25], especially if compared with the structural complexity of nervous system. A reliable solution to this question resides in three-dimensional (3D) biomaterial scaffolds that show a great potential as engineered neural tissue for cell-based therapy[26,27].

This review integrates the basic physiology of ASC with the functional modifications of cell phenotype furnished by enrichment of microenvironment with appropriate biophysical, biomechanical and biochemical stimuli. In particular, the effects of chemicals-like drugs and growth factors-biomaterial and microgravity are discussed as both single and co-applied parameters for inducing ASCs toward the neural lineage.

NEURAL CELLS FROM ASCs, WHY IS IT DESIRABLE?

SCs are defined as unspecialized cells capable of self-renewing and of giving rise to a wide range of mature cell types[28]. During their proliferation, SCs do not follow the classical asymmetric cell division that generates a SC and a differentiated daughter at each division. Their “potential” resides in generating more SC and differentiated daughters[29]. Two types of SCs have been classified following their origin and their potential of differentiation: Embryonic tem cells (ESCs) and somatic SCs.

The ESCs derive from the early blastocyst and the inner cell mass of the embryo and are able to differentiate into cell types of the three germ layers[30]. Even if they represent the most powerful tool for cell therapy in animal models, their application is associated to ethical issue and to high degree of variation with regard to differentiation potential due to their genetic and epigenetic instability.

The somatic SCs are obtained from fetal (after gastrulation) or adult tissues and traditionally differentiate only toward cell types that belong to the tissue which they originate from. Among the adult tissues, somatic SC have been isolated from bone marrow[31], brain[32], blood[33], epidermis[34], skeletal muscle[35] and fat[10]. In each tissue, somatic SCs guarantee the maintaining of tissue homeostasis, but their action in replacing damaged cells after intense insults is limited by a mostly quiescent status or a weak activity. This is the case of neural stem cells (NSCs), located in adult mammals within a cellular niche[36] in the sub-ependymal layer of the ventricular zone and in the dentate gyrus of the hippocampus[37]. However, even if these differentiate in vitro into neurons, astrocytes and oligodendrocytes[38], they are not effective in containing neurodegenerative process.

The adult SCs offer the potential for autologous stem cell donation, reducing the risk of immune rejection and complications[39] and are additionally far from ethical and religious debates. We underscore that these advantages represent a solid basis for cultural renaissance and for scientific efforts to define the best source of adult SCs and to optimize methods for a safe, controlled and long-lasting differentiation.

According to our experience, the first description of a population of cells derived from human adipose tissue with a multilineage differentiation and high proliferation capacity in vitro[9] represents the milestone for scientific awakening and for overcoming specific tissue-linked limitations. Compared to bone marrow, adipose tissue is obtained with a not invasive, well-tolerated and safe procedure such as liposuction surgery. Moreover, the yield of obtained cells is relatively higher than other stem cell sources[40] and the digestion of lipoaspirate permits to isolate approximately from 0.5 × 104 to 2 × 105 stem cells per gram of adipose tissue[41]. Furthermore, ASCs can be cultured for several months in vitro with low levels of senescence[10]. The latter aspect is essential because it turns into a reduction of permanent post-mitotic states and the cells remain viable and proliferative over extensive periods during which the terminal differentiation could be stimulated. Thus, the critical point is the induction of a stable phenotype not restricted to mesodermal cells but including the ectodermal ones.

There is a diffuse disagreement about pluripotential properties of ASCs, but in our experience the phenotype of ASCs can be addressed toward mesodermal[12,14] and non-mesodermal lineages[20]. In these observations reside the scientific efforts in the evaluation of ASCs as tools for generation of neural cells to apply in cell therapy strategies and in cell models for various neurodegenerative disorders[42].

Because non-neural differentiation potential falls outside of the scope of the present review, we focus on in vitro methods to induce neural differentiation. A systematic literature search was conducted using PubMed, WoS, and Scopus. Studies providing only results for in vitro neural phenotype induction from ASCs and preclinical examination were included. When preliminary tests on animal model of diseases have been performed, the major relevant findings were discussed.

IN VITRO METHODS TO INDUCE NEURAL DIFFERENTIATION OF ASCs

The experimental conditions of ASCs neural induction and differentiation contemplate at least three main categories or microenvironment factors: (1) The elaboration of chemically-defined or growth factors-enriched media; (2) the creation of a functionalized tree-dimensional structure by biomaterials; and (3) the application of appropriate biophysical forces.

GROWTH FACTORS AND CHEMICALS FOR ASCs NEURAL DIFFERENTIATION

The most applied protocols for neural differentiation of ASCs are designed as “run-through” procedures, in which ASCs are sequentially propagated in different media enriched by growth factors or chemicals until they transdifferentiate into a desired phenotype. These approaches should be defined “physiological-inspired” or “chemical-based” as they try to mimic in vitro the complex environment of nervous system by adding growth factors or chemicals.

In the earlier reports, a two-steps method has been adopted and a phase of cellular preconditioning or induction was followed by application of differentiation stimuli. As preconditioning media, Safford et al[43] tested the enrichment with epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF), whereas Zuk et al[10] used DMEM supplemented by 20% of fetal bovine serum and β-mercaptoethanol. After this step, the neuronal differentiation was performed by medium composed of DMEM plus butylated hydroxyanisole, KCl, valproic acid, forskolin, hydrocortisone, and insulin or by a serum-free and β-mercaptoethanol-enriched medium, respectively. In both experimental conditions, ASCs developed to an early neuronal stage, as no expression of established oligodendrocyte and astrocyte markers or mature neuronal markers were observed. These two works are milestones for neuronal differentiation of ASCs, but they lacked in electrophysiological tests. Indeed, a delayed-rectifier type K+ current (an early developmental ion channel) concomitantly with morphologic changes and increased expression of neural-specific markers suggested that ASCs differentiate toward early progenitors of neurons and/or glia after 2 wk in differentiating medium with isobutylmethylxanthine, indomethacin, and insulin[44]. The pre-induction was also performed by bFGF for seven days[19] or for twenty-four hours[45], following the incubation with forskolin alone[19] or in combination with N2 supplement, butylated hydroxyanisole, KCl, valproic acid[45]. Despite the similar protocol, the relevant findings were different. Krampera et al[45] reported a transient and reversible differentiation within 48-72 h of culture with basal medium. Indeed, in the protocol of Jang et al[19], the acquired neuron-like functions were demonstrated by evaluation of voltage-dependent tetrodotoxin (TTX)-sensitive sodium currents, outward potassium currents, and prominent negative resting membrane potentials. These events underscore that the in vitro microenvironment is capable to infer with the multiple functional ion channel currents that are physiologically present in undifferentiated ASCs[46].

Another approach showed morphological, immunocytochemical and electrophysiological evidences of stable neuronal differentiation of ASCs. It is based on the induction of floating sphere in serum-free medium in presence of bFGF, and EGF. The spheres were dissociated in single cells and cultured with brain derived neurotrophic factor (BDNF) and retinoic acid[47]. It was also investigated the possibility to transdifferentiate ASCs by using neural induction medium (high glucose DMEM, β-mercaptoethanol, and butylated hydroxyanisole) supplemented with and 10% of autologous platelet-rich plasma (PRP) isolated and prepared from venous blood of the same patient underwent liposuction[48]. Some reports showed an induction toward a neural-like phenotype by media previously conditioned thought incubation with neuroblastoma or olfactory ensheathing cells (OECs)[49] or with ASCs induced to secrete neurotrophic factors[50] in presence of estrogen[51], also.

All the major protocols considered for differentiation of ASCs to neural cells have been reviewed by linking them to the neural markers that should be used in each procedure and the possible pathways that are involved in this process[52]. Here we focus on the physiological input trying to define a profile that links chemicals and growth factors to ASCs fate.

According to the studies performed up to now, EGF and bFGF seem able to induce a useful pre-conditioning microenvironment for ASCs induction toward ectodermal lineage[53]. The co-administration of EGF and bFGF is essential because, as shown in Table 1, when tested alone on ASCs, EGF acts to promote ASCs proliferation by robust phosphorylation of SHC and ERK1/2[54], to induce migration, to delay senescence, and to maintain differentiation potency by EGF-induced activation of STAT signal pathway[55]. Indeed, bFGF alone enhances the proliferation, and the hepatocyte growth factor expression ability of ASCs[58], promoting the adipogenic[59] and chondrogenic[60] differentiation with the contemporary inhibition of the osteogenic one[61]. This biochemical event happens because ASCs express EGF and bFGF receptors[54]. Furthermore, they express PDGF receptors α and β. PDGFR-α is highly expressed, but its ligand only slightly increases the proliferation of ASCs. Therefore, it is reasonable to assume that PDGF-β and PDGF receptor-β signalling is involved primarily in the stimulation of ASCs[62]. PDGF is released from activated platelets on bleeding, thus the stimulation with autologous platelet-rich plasma (PRP) represents an effective method to mediate stimulatory effect on cell proliferation, to increase the yield of ASCs and to reduce the cost of ASCs differentiation. In the same manner, the incubation with conditioned media appears a good technique for introducing an enriched cocktail of growth factors with positive remarks at both financial and practical point of view. Specifically, the secretome of neuroblastoma B104 cells has been reported to contain PDGF-AA, bFGF and IGF-1[63], whereas brain derived neurotrophic factor (BDNF), nerve grown factor (NGF), neurotrophin-4/5 (NT-4/5), neuregulin, secreted protein acidic rich in cysteine (SPARC) and matrix metalloproteinase-2 (MMP-2) have been reported as typical elements of OECs secretoma. Among these growth factors, nerve grown factor-β (NGF-β), BDNF, and neurotrophin-3 (NT-3) were applied on EGF plus bFGF-preconditioned ASCs to induce a neural-like phenotype[20].

Table 1 Functions of growth factors on neural induction of adipose stem cells.
Growth factorsProfilePhysiological activityEffect on ASCsRemarks
EGFSmall polypeptide of 53 amino acid residues and a molecular mass of approximately 6000 daltons[57]Development of the oral cavity, lungs, gastrointestinal tract, epidermis, derma, eyelids and central nervous system[56]Promotion of proliferation with delays of senescence and insurance of differentiation potency[55]EGF and bFGF co-administration limits ASCs differentiation abilities by inducing ASCs into an ectodermal lineage rather than the mesodermal one[53]
bFGFNon-glycosylated polypeptide of 18 kDa and 155 amino acid in length (heparin-binding growth factor family)Stimulator of tissue repair and cellular viability released from an injured extracellular matrix[64]Enhancement of proliferation, differentiation and hepatocyte growth factor expression ability[58]. Induction of the adipogenic[59] and chondrogenic[60] potential, with inhibition of osteogenic differentiation[61]
PDGFDimeric glycoproteinPotent mitogen for cell of mesodermal lineage and stimulator of tissue repair released from activated platelets on bleeding[65]Supporting of cell proliferation in vitro: It increases ASCs yield. Promotion of neural differentiation in an antioxidant microenvironment[48]Receptor-β signalling is involved primarily in ASCs stimulation[62]. ASCs stimulation with autologous platelet-rich plasma reduces the cost of differentiation[48]

Thus, the growth factors that physiologically act in tissue rapid turnover[56,64,65] seem to stimulate proliferation and to improve responsiveness of ASCs toward ectodermal-derived stimuli. From this basic speculation, the major question must be opened is addressed to define what happens in humans with neurodegenerative syndromes, or in which way the loss or the increase of a biochemical stimulus expression may interfere into ASCs phenotype by enhancing or limiting clinical application. Up to now, no scientific result can drive to answer.

Among the chemical reagents, the major applied ones were antioxidants or compounds active on DNA (Table 2).

Table 2 Effects of chemicals-enriched microenvironment on adipose stem cells fate.
ActionChemicals/drugsProfileRecognized functionEffects on ASCs
Antioxidantβ-mercaptoethanolWater-soluble thiol used as a reducing agent for disulfide bonds to protect sulfhydryl groups from oxidationIn peripheral intestinal nervous system increases the number of synapses and the vesicle population in the nerve terminals[69]Key elements for the neural induction medium: Reduction of oxidative stress and reactive oxygen species production could support neural population
Improve meiotic maturation in vitro cultured oocytes[70]
Butylated hydroxyanisoleMixture of two isomeric organic compoundsInhibition of 17 β-estradiol(E2)-mediated oxidative stress and of oxidative DNA damage
N-acetyl-l-cysteineSynthetic derivative of endogenous amino acid, L-cysteine, precursor of the antioxidant enzyme GlutathioneStimulator of glutathione synthase Activator of NMDA1 receptorWhen co-administrated, reduction of ASCs-doubling time and increase of cell number compared with b-FGF alone supplementation[66]
Ascorbic acid-2-phosphate (Vitamin C)Water-soluble essential vitaminReducing agent and coenzyme in several metabolic pathways
Interference on DNAValproic acidBranch-chained fatty acid, acting as a histone deacetylase inhibitorWide range of neuroprotection[71,72] Inhibitor of glycogen synthase kinase-3[73] Inducer of chromatin remodeling[74]Promoter of neuron-like cells[75] In vivo, it improves homing of ASCs via overexpression of CXCR4 and CXCR6[76]
5-azacytidineAnalog of cytidine nucleoside, acting as demethylating agent[77,78]Inducer of cell plasticity and active molecule for cellular differentiation into multiple phenotype[79]Stimulated-cells ameliorate neurological deficits when injected in rats after cerebral ischemia[80]
Anti-inflammationIndomethacinSynthetic nonsteroidal indole derivativeInhibitor of COX1/2Component of neural induction medium applied for two weeks[44]
Immuno modulationHydrocortisoneGlucocorticoid hormoneSuppressor of cell-mediate immunityForm multi-nucleated myotubes, yielding protein markers for myocytes[9]
Energetic balanceN2 supplementChemically defined formulation containing insulin, transferrin, progesterone, putrescine and seleniteIn vitro survival and expression of post-mitotic neurons in primary cultures from both the peripheral nervous system and the central nervous systemGeneral promotion of neural cell survival
B27 supplementMixture of vitamins (biotin, Tocopherol, Vitamin A), proteins (BSA, catalase, insulin transferrin, superoxide dismutase), Corticosterone, Galactose, Ethanolamine, Glutathione, Carnitine, Linoleic acid, linolenic acid, progesterone, putrescine, selenite, T3Growth and maintenance of neurons. Differentiating Glial Precursor Cells into Astrocytes and Oligodendrocytes. Differentiating Neural Stem Cells into Neurons and Glial Cells

An antioxidant microenvironment, obtained by N-acetyl-l-cysteine and ascorbic acid-2-phosphate, has been reported to reduce ASCs-doubling time and to increase cell number[66]. The β-mercaptoethanol sustained the induction of neural phenotype after pre-induction and differentiation[10], whereas the butylated hydroxyanisole promoted the neural stem cell survival. All these beneficial effects of antioxidants toward a neural phenotype should be related to the essential role that a pro-oxidant microenvironment exerts on induction of adipogenic phenotype[67]. It has been recently demonstrated that oxidative stress and reactive oxygen species (ROS) overproduction could drive the activation of molecular pathways that are able to convert myoblasts into brown adipocytes[68]. Nevertheless, the B27 reagent, that is routinely applied in laboratory’s procedures for the growth and maintenance of neurons or for differentiating of SCs into neurons and glial cells, contains tocopherol, Vitamin A, catalase, superoxide dismutase, glutathione, that, among the other effects, are largely described for their propriety of oxidative stress-limiting agents.

The drugs active on DNA usually applied for neural induction of ASCs are histone deacetylase (HDAC) inhibitors or methylation inhibitors, like the valproic acid and the 5-azacytidine, respectively. The valproic acid is commonly used for the treatment of seizures and bipolar disorder. Valproic acid demonstrated a wide range of neuroprotective properties in cellular and animal models of neurodegenerative diseases[71,72], probably for the activity as both toward the inhibition of glycogen synthase kinase-3 (GSK-3)[73] and the enhancement of CXCR4 expression[74]. In ASCs, in vitro treatment with valproic acid resulted in a promotion of neuron-like differentiation[75] and in vivo an enhanced homing of ASCs was reported via overexpression of CXCR4 and CXCR6[76]. Indeed, the demethylating agent 5-azacytidine is commonly employed to treat blood disorders such as myelodysplasia and leukemia[77]. It has been historically described as an inducer of cell plasticity and as an active molecule for cellular differentiation into multiple phenotypes[78,79]. The enrichment of ASCs microenvironment with 5-azacytidine has been effective to improve neural differentiation and to ameliorate neurological deficits after cerebral ischemia in rats[80].

Thus, the media formulation for ASCs neural differentiation is very far from a “magic recipe”, but its definition, amelioration and reproducibility should necessary start not only from ASCs physiology but also from the analysis of their reactivity toward environmental stimuli. We think this aspect is essential especially with a clinical application in mind.

BIOMATERIALS FOR ASCs NEURAL DIFFERENTIATION

Chemicals and growth factors act as signal transducers to induce ASCs toward a neural-like phenotype, but the control of their differentiation toward a specific and stable lineage requires not only a controlled biochemical microenvironment, but also a milieu in which cell-cell and cell-environment interactions should be evaluated in a three-dimensional architecture. Biomaterials offer the possibility to deliver stem cell regulatory signals in a precise and near physiological manner without the exclusion of 3D space as parameter.

The effectiveness of biomaterials in driving ASCs differentiation has been already reported for their differentiation into epithelial cells. It was emblematic and noteworthy the geometric dependence of ASCs phenotype in fibrin culture[81]. In this well-conducted study, the experimental plan demonstrated clearly that the growth factor-enriched medium increased ASCs growth and chemotaxis, but the differentiation into epithelial cells was effective only in a 3D structure of fibrin. In this condition, the authors identified the formation of a bilayer of two segregate cell phenotypes: The superficial one with ASCs-derived epithelial cells and the deeper one with mesenchymal cells. This evidence strongly suggests that biomaterials may allow the control of proliferation and differentiation not only of ASCs, but also of their neural derivatives, because it is possible the hypothesis of biomaterials that should act by reducing ASCs propagation after differentiation and by maintaining a niche of ASCs with high level of stemness to be reprogrammed according to tissue necessity.

Table 3 summarizes the principal biomaterials for neural differentiation of ASCs investigated in preclinical studies. The spontaneous formation of three-dimensional spheroids has been reported by using chitosan, a naturally derived polysaccharide from chitin[82,83]. ASCs spheroids were formed on chitosan films because pure chitosan cannot support adequate cell adhesion for its biophysical parameter. This propriety enhanced spontaneous cell organization in a 3D architecture that permitted the close association of cells and a transmission of signal cues easier and faster than in monolayer cultures. Considering that chitosan lacks biological activity, the upregulation of pluripotency marker genes[82], the transdifferentiation efficiency into neural-like cells[83] or neuron[82] in vitro, and the higher cellular retention ratio of ASC spheroids after intramuscular injection in nude mouse[82] could be justified by the 3D organization of cells.

Table 3 Biomaterials for neural phenotype of adipose stem cells.
BiomaterialsProfileEffect on ASCsTest on animalLimitation for clinical
Chitosan filmsNaturally derived polysaccharide from chitin[81,82]Spontaneous cell organization in a 3D architectureYes, higher cellular retention ratio of ASC spheroids after intramuscular injection in nude mouse[81]Not declared
Chitosan and gelatinElastic-dominant, porous scaffoldConditioning toward a neuron-like phenotypeYes, better repair in a mouse model of traumatic brain injury[83]Not declared
Chitosan and silkComplex structural frameworkEfficient as delivery vehicle for ASCsYes, proposed as nerve grafts in the regeneration of injured rat sciatic nerve[84]Not declared
Collagen gelEngineered neural tissueCells must be aligned to collagen fibresYes, supported robust neural regeneration of injured rat sciatic nerve[85]Not declared
AlbuminSerum-derived porous scaffoldPromotion toward neuronsYes, filler effect on the spinal cord cavity in animal models of spinal cord injury[86]Not declared
MatrigelCommercially available hydrogelGood cell encapsulation and delivery[87]Yes, mouse models of spinal cord injuryNot applicable for its isolation from the basement membrane of a mouse sarcoma
AlginateHydrogelNeurospheres encapsulation and neural promotion[88,89]Good biocompatible profile
Nanosized graphene oxide-laminin hybrid patternsEngineered tissueEfficient neuron-like cells differentiation[90]

Moreover, chitosan combinations with gelatin or silk were tested in animal models of neurodegeneration. In the case of elastic-dominant, porous scaffolds from photocurable, chemically modified chitosan and gelatin, ASCs were conditioned toward neuron-like cells capable to better repair a traumatic brain injury mouse model[84]. Indeed, the chitosan/silk fibroin scaffold has been proposed as nerve grafts for its efficiency as delivery vehicle for ASCs and as structural framework in the regeneration of injured rat sciatic nerve[85]. In the same animal model, an engineered neural tissue (EngNT) composed by collagen gel and aligned rat ASCs supported robust neural regeneration across the gap and into the distal stump[86]. Similar efficiency was proved in animal models of spinal cord injury after implantation of ASCs seeded on serum-derived albumin scaffold, a porous biomaterial that completely filled the spinal cord cavity and permitted the passage of descending and ascending neurons[87]. Similar results have been obtained by using Matrigel[88], a commercially available hydrogel that, because of its isolation from the basement membrane of a mouse sarcoma, is unlikely to be approved for clinical use. To select the hydrogels, the patient safety should be always considered in order to perform translational researches. For example, the alginate hydrogel-that has been used to encapsulate neurospheres obtained from neural differentiation of ASCs[89,90]-had a good biocompatible profile.

More recently, nanosized graphene oxide (NGO)-laminin hybrid patterns were reported to be useful for ASCs transdifferentiation into neuron-like cells that were up to 30% higher than the control group. In the same work, it was proved that cells grown on NGO grid patterns were more differentiated than the other ones grown on PLL-coated Au or on NGO-coated Au[91].

Taken together, all these results strongly suggest that biomaterials provide a benefit for neural differentiation of ASCs: They should mimic the shape of interconnected neuronal network and the nanoscale topographical features of the extracellular matrix, as already reported for the nanoengineered polystyrene surface containing nanopore array-patterned substrate[92]. Moreover, biomaterials have been applied to realize an electrical cell culture system for selective induction of neurons. This in vitro technique is realized by cellular seeding on the conductive polypyrrole/chitosan membrane with a thickness of 0.4 mm. The membrane can be connected to an electric stimulator by two thin platinum electrodes. In this way, a defined electric intensity can be applied to cell culture (V/cm). It has been employed on Schwann cells[93], on OECs[94] and on mouse bone marrow stromal cells[95] to induce and sustain their phenotype regulation. Yang et al[96] applied it on ASCs; they tested the possibility to promote neuronal differentiation by using both electrical stimulation and Nurr-1 gene transduction alone and in combination. The results clearly evidenced that both electrical extracellular microenvironments and intracellular patter profile were capable of promoting neuronal differentiation in ASCs, but the best result was achieved by a synergistically combination of electrical forces and genetic modification.

BIOPHYSICAL FORCES TO DRIVE NEURAL CELLS FROM ASCs

Biophysical forces, particularly the electro-mechanical coupling and the deformation forces are important physiological regulators of nervous systems. Actually, microgravity, as a mechanical factor, is more and more under investigation, especially for its implication in heath of spaceflights and astronauts in orbit. As summarized by Mariggiò and Fanò-Illic[97], the microgravity effects are not fully characterized and contrasting events have been reported: In some cases, cell differentiation and tissue assembly were not affected by microgravity, indeed in other cases alteration of cell morphology and function has been reported. For this reason, a three-dimensional glia–neuron co-culture cell model has been proposed as useful tool for the investigation of microgravity as a new environment to successfully manipulate cell functions and phenotype. Generally, in monolayer tissue, an improvement of stem cell differentiation into neurons was reported for PC12 neuron-like cell[98] and for ESCs[99].

As about ASCs, the microgravity effect is very little known. Up to now, only a single and recent study tried to define a mechanistic link between microgravity and neural induction of ASCs[100]. In this experimental setup, it was found that microgravity stimulation with a clinostat instrument increased ASCs differentiation toward neural-like cells in presence of the classical chemically defined and growth factor enriched medium. Even if the differentiation was proved by evaluation of neural cell lineage markers, no data about the specific effect of microgravity have been produced. Thus, it remains unclear if microgravity alone can modify the cell phenotype in absence of growth factors and biochemical stimuli, also.

CONCLUSION

Since ASCs can be readily isolated, expanded and transplanted, their application in cell-based therapies is more and more under investigation. The differentiation of ASCs was initially considered restricted to mesodermal cells, but recent advances display ASCs ability to transdifferentiate, acquiring cell phenotype different from mesenchymal, including the ectodermal one. In the past decade, most of researches focused of the promotion of ASCs into neural-like cells for evaluating their potential application in neurodegenerative disorders. Different strategies were adopted. Among them, the cultures in chemically defined or growth factors-enriched media were applied to stimulate in vitro the physiological process of neural induction. This dynamic event involves many biological processes and signaling events that can be potentiated by the elaboration of an appropriate biophysical and biochemical microenvironment and should be evaluated in a 3D architecture. In this context, biomaterials provide a sophisticated microenvironment. Even if terminally differentiated, functional neurons have yet to be achieved, the reported data from animal tests have shown that some biomaterials have a great potential as nerve grafts. A synergic work between cell and tissue physiologists and biomaterial production experts seems to be useful for the future development of ASCs-based clinical therapeutics to be employed in neurodegenerative disorders.

Footnotes

Manuscript source: Invited manuscript

Specialty type: Cell and tissue engineering

Country of origin: Italy

Peer-review report classification

Grade A (Excellent): 0

Grade B (Very good): B

Grade C (Good): C

Grade D (Fair): 0

Grade E (Poor): 0

P- Reviewer: Jun YM, Maraldi T S- Editor: Cui LJ L- Editor: A E- Editor: Song XX

References
1.  Wee Yong V. Inflammation in neurological disorders: a help or a hindrance? Neuroscientist. 2010;16:408-420.  [PubMed]  [DOI]
2.  Avola R, Graziano AC, Pannuzzo G, Alvares E, Cardile V. Krabbe’s leukodystrophy: Approaches and models in vitro. J Neurosci Res. 2016;94:1284-1292.  [PubMed]  [DOI]
3.  Parveen S, Goberman AM. Comparison of self and proxy ratings for voice handicap index and motor-related quality-of-life of individuals with Parkinson’s disease. Int J Speech Lang Pathol. 2017;19:174-183.  [PubMed]  [DOI]
4.  Avola R, Graziano ACE, Pannuzzo G, Albouchi F, Cardile V. New insights on Parkinson’s disease from differentiation of SH-SY5Y into dopaminergic neurons: An involvement of aquaporin4 and 9. Mol Cell Neurosci. 2018;88:212-221.  [PubMed]  [DOI]
5.  Garg H, Bush S, Gappmaier E. Associations Between Fatigue and Disability, Functional Mobility, Depression, and Quality of Life in People with Multiple Sclerosis. Int J MS Care. 2016;18:71-77.  [PubMed]  [DOI]
6.  Block VA, Pitsch E, Tahir P, Cree BA, Allen DD, Gelfand JM. Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review. PLoS One. 2016;11:e0154335.  [PubMed]  [DOI]
7.  Graziano AC, Cardile V. History, genetic, and recent advances on Krabbe disease. Gene. 2015;555:2-13.  [PubMed]  [DOI]
8.  Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012;2012:812693.  [PubMed]  [DOI]
9.  Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211-228.  [PubMed]  [DOI]
10.  Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279-4295.  [PubMed]  [DOI]
11.  Cawthorn WP, Scheller EL, MacDougald OA. Adipose tissue stem cells: the great WAT hope. Trends Endocrinol Metab. 2012;23:270-277.  [PubMed]  [DOI]
12.  Lo Furno D, Graziano AC, Avola R, Giuffrida R, Perciavalle V, Bonina F, Mannino G, Cardile V. A Citrus bergamia Extract Decreases Adipogenesis and Increases Lipolysis by Modulating PPAR Levels in Mesenchymal Stem Cells from Human Adipose Tissue. PPAR Res. 2016;2016:4563815.  [PubMed]  [DOI]
13.  Musumeci G, Mobasheri A, Trovato FM, Szychlinska MA, Graziano AC, Lo Furno D, Avola R, Mangano S, Giuffrida R, Cardile V. Biosynthesis of collagen I, II, RUNX2 and lubricin at different time points of chondrogenic differentiation in a 3D in vitro model of human mesenchymal stem cells derived from adipose tissue. Acta Histochem. 2014;116:1407-1417.  [PubMed]  [DOI]
14.  Graziano ACE, Avola R, Pannuzzo G, Cardile V. Aquaporin1 and 3 modification as a result of chondrogenic differentiation of human mesenchymal stem cell. J Cell Physiol. 2018;233:2279-2291.  [PubMed]  [DOI]
15.  Halvorsen YD, Franklin D, Bond AL, Hitt DC, Auchter C, Boskey AL, Paschalis EP, Wilkison WO, Gimble JM. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng. 2001;7:729-741.  [PubMed]  [DOI]
16.  Choi YS, Matsuda K, Dusting GJ, Morrison WA, Dilley RJ. Engineering cardiac tissue in vivo from human adipose-derived stem cells. Biomaterials. 2010;31:2236-2242.  [PubMed]  [DOI]
17.  Choi SA, Lee JY, Wang KC, Phi JH, Song SH, Song J, Kim SK. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas. Eur J Cancer. 2012;48:129-137.  [PubMed]  [DOI]
18.  Lindroos B, Suuronen R, Miettinen S. The potential of adipose stem cells in regenerative medicine. Stem Cell Rev. 2011;7:269-291.  [PubMed]  [DOI]
19.  Jang S, Cho HH, Cho YB, Park JS, Jeong HS. Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biol. 2010;11:25.  [PubMed]  [DOI]
20.  Avola R, Graziano ACE, Pannuzzo G, Cardile V. Human Mesenchymal Stem Cells from Adipose Tissue Differentiated into Neuronal or Glial Phenotype Express Different Aquaporins. Mol Neurobiol. 2017;54:8308-8320.  [PubMed]  [DOI]
21.  Casteilla L, Dani C. Adipose tissue-derived cells: from physiology to regenerative medicine. Diabetes Metab. 2006;32:393-401.  [PubMed]  [DOI]
22.  Keung EZ, Nelson PJ, Conrad C. Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy. Stem Cells. 2013;31:227-235.  [PubMed]  [DOI]
23.  Esfandiari B, Soliemani M, Kaviani S, Parivar K. Rapid Neural Differentiation of Human Adipose Tissue derived Stem Cells Using NGF, Forskolin and bFGF. Biomed Pharm J. 2016;9:39-48.  [PubMed]  [DOI]
24.  Dai R, Wang Z, Samanipour R, Koo KI, Kim K. Adipose-Derived Stem Cells for Tissue Engineering and Regenerative Medicine Applications. Stem Cells Int. 2016;2016:6737345.  [PubMed]  [DOI]
25.  Cukierman E, Pankov R, Yamada KM. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol. 2002;14:633-639.  [PubMed]  [DOI]
26.  Edelman DB, Keefer EW. A cultural renaissance: in vitro cell biology embraces three-dimensional context. Exp Neurol. 2005;192:1-6.  [PubMed]  [DOI]
27.  Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R, Schoen FJ, Toner M, Mooney D, Atala A. Engineering complex tissues. Tissue Eng. 2006;12:3307-3339.  [PubMed]  [DOI]
28.  Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood. 2003;102:3483-3493.  [PubMed]  [DOI]
29.  Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature. 2006;441:1068-1074.  [PubMed]  [DOI]
30.  Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA. 2000;97:11307-11312.  [PubMed]  [DOI]
31.  Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17:331-340.  [PubMed]  [DOI]
32.  Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255:1707-1710.  [PubMed]  [DOI]
33.  Domen J, Weissman IL. Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate. Mol Med Today. 1999;5:201-208.  [PubMed]  [DOI]
34.  Gandarillas A, Watt FM. c-Myc promotes differentiation of human epidermal stem cells. Genes Dev. 1997;11:2869-2882.  [PubMed]  [DOI]
35.  Seale P, Rudnicki MA. A new look at the origin, function, and “stem-cell” status of muscle satellite cells. Dev Biol. 2000;218:115-124.  [PubMed]  [DOI]
36.  Rossi F, Cattaneo E. Opinion: neural stem cell therapy for neurological diseases: dreams and reality. Nat Rev Neurosci. 2002;3:401-409.  [PubMed]  [DOI]
37.  Gage FH. Neurogenesis in the adult brain. J Neurosci. 2002;22:612-613.  [PubMed]  [DOI]
38.  McKay R. Stem cells in the central nervous system. Science. 1997;276:66-71.  [PubMed]  [DOI]
39.  Reisman M, Adams KT. Stem cell therapy: a look at current research, regulations, and remaining hurdles. P T. 2014;39:846-857.  [PubMed]  [DOI]
40.  Illouz YG. Body contouring by lipolysis: a 5-year experience with over 3000 cases. Plast Reconstr Surg. 1983;72:591-597.  [PubMed]  [DOI]
41.  Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z. Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct. 2008;26:664-675.  [PubMed]  [DOI]
42.  Graziano ACE. Is it Time to Study Leukodystrophies? J Neurosci Rural Pract. 2017;8:S1-S2.  [PubMed]  [DOI]
43.  Safford KM, Hicok KC, Safford SD, Halvorsen YD, Wilkison WO, Gimble JM, Rice HE. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun. 2002;294:371-379.  [PubMed]  [DOI]
44.  Ashjian PH, Elbarbary AS, Edmonds B, DeUgarte D, Zhu M, Zuk PA, Lorenz HP, Benhaim P, Hedrick MH. In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg. 2003;111:1922-1931.  [PubMed]  [DOI]
45.  Krampera M, Marconi S, Pasini A, Galiè M, Rigotti G, Mosna F, Tinelli M, Lovato L, Anghileri E, Andreini A. Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone. 2007;40:382-390.  [PubMed]  [DOI]
46.  Bai X, Ma J, Pan Z, Song YH, Freyberg S, Yan Y, Vykoukal D, Alt E. Electrophysiological properties of human adipose tissue-derived stem cells. Am J Physiol Cell Physiol. 2007;293:C1539-C1550.  [PubMed]  [DOI]
47.  Anghileri E, Marconi S, Pignatelli A, Cifelli P, Galié M, Sbarbati A, Krampera M, Belluzzi O, Bonetti B. Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. Stem Cells Dev. 2008;17:909-916.  [PubMed]  [DOI]
48.  Li H, Han Z, Liu D, Zhao P, Liang S, Xu K. Autologous platelet-rich plasma promotes neurogenic differentiation of human adipose-derived stem cells in vitro. Int J Neurosci. 2013;123:184-190.  [PubMed]  [DOI]
49.  Lo Furno D, Pellitteri R, Graziano AC, Giuffrida R, Vancheri C, Gili E, Cardile V. Differentiation of human adipose stem cells into neural phenotype by neuroblastoma- or olfactory ensheathing cells-conditioned medium. J Cell Physiol. 2013;228:2109-2118.  [PubMed]  [DOI]
50.  Razavi S, Razavi MR, Kheirollahi-Kouhestani M, Mardani M, Mostafavi FS. Co-culture with neurotrophic factor secreting cells induced from adipose-derived stem cells: promotes neurogenic differentiation. Biochem Biophys Res Commun. 2013;440:381-387.  [PubMed]  [DOI]
51.  Razavi S, Razavi MR, Ahmadi N, Kazemi M. Estrogen treatment enhances neurogenic differentiation of human adipose derived stem cells in vitro. Iran J Basic Med Sci. 2015;18:799-804.  [PubMed]  [DOI]
52.  Salehi H, Amirpour N, Niapour A, Razavi S. An Overview of Neural Differentiation Potential of Human Adipose Derived Stem Cells. Stem Cell Rev. 2016;12:26-41.  [PubMed]  [DOI]
53.  Hu F, Wang X, Liang G, Lv L, Zhu Y, Sun B, Xiao Z. Effects of epidermal growth factor and basic fibroblast growth factor on the proliferation and osteogenic and neural differentiation of adipose-derived stem cells. Cell Reprogram. 2013;15:224-232.  [PubMed]  [DOI]
54.  Baer PC, Schubert R, Bereiter-Hahn J, Plösser M, Geiger H. Expression of a functional epidermal growth factor receptor on human adipose-derived mesenchymal stem cells and its signaling mechanism. Eur J Cell Biol. 2009;88:273-283.  [PubMed]  [DOI]
55.  Ai G, Shao X, Meng M, Song L, Qiu J, Wu Y, Zhou J, Cheng J, Tong X. Epidermal growth factor promotes proliferation and maintains multipotency of continuous cultured adipose stem cells via activating STAT signal pathway in vitro. Medicine (Baltimore). 2017;96:e7607.  [PubMed]  [DOI]
56.  Carpenter G, Goodman L, Shaver L. The Physiology of Epidermal Growth Factor. In: Kahn P, Graf T. Oncogenes and Growth Control. Springer, Berlin, Heidelberg; 1986;.  [PubMed]  [DOI]
57.  Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962;237:1555-1562.  [PubMed]  [DOI]
58.  Tang WP, Akahoshi T, Piao JS, Narahara S, Murata M, Kawano T, Hamano N, Ikeda T, Hashizume M. Basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor. J Gastroenterol Hepatol. 2015;30:1065-1074.  [PubMed]  [DOI]
59.  Kakudo N, Shimotsuma A, Kusumoto K. Fibroblast growth factor-2 stimulates adipogenic differentiation of human adipose-derived stem cells. Biochem Biophys Res Commun. 2007;359:239-244.  [PubMed]  [DOI]
60.  Kabiri A, Esfandiari E, Hashemibeni B, Kazemi M, Mardani M, Esmaeili A. Effects of FGF-2 on human adipose tissue derived adult stem cells morphology and chondrogenesis enhancement in Transwell culture. Biochem Biophys Res Commun. 2012;424:234-238.  [PubMed]  [DOI]
61.  Quarto N, Longaker MT. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng. 2006;12:1405-1418.  [PubMed]  [DOI]
62.  Hye Kim J, Gyu Park S, Kim WK, Song SU, Sung JH. Functional regulation of adipose-derived stem cells by PDGF-D. Stem Cells. 2015;33:542-556.  [PubMed]  [DOI]
63.  Hu JG, Wu XJ, Feng YF, Xi GM, Wang ZH, Zhou JS, Lü HZ. PDGF-AA and bFGF mediate B104CM-induced proliferation of oligodendrocyte precursor cells. Int J Mol Med. 2012;30:1113-1118.  [PubMed]  [DOI]
64.  Muthukrishnan L, Warder E, McNeil PL. Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells. J Cell Physiol. 1991;148:1-16.  [PubMed]  [DOI]
65.  Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83:835-870.  [PubMed]  [DOI]
66.  Sun LY, Pang CY, Li DK, Liao CH, Huang WC, Wu CC, Chou YY, Li WW, Chen SY, Liu HW. Antioxidants cause rapid expansion of human adipose-derived mesenchymal stem cells via CDK and CDK inhibitor regulation. J Biomed Sci. 2013;20:53.  [PubMed]  [DOI]
67.  Han J, Choi HY, Dayem AA, Kim K, Yang G, Won J, Do SH, Kim JH, Jeong KS, Cho SG. Regulation of Adipogenesis Through Differential Modulation of ROS and Kinase Signaling Pathways by 3,4’-Dihydroxyflavone Treatment. J Cell Biochem. 2017;118:1065-1077.  [PubMed]  [DOI]
68.  Morozzi G, Beccafico S, Bianchi R, Riuzzi F, Bellezza I, Giambanco I, Arcuri C, Minelli A, Donato R. Oxidative stress-induced S100B accumulation converts myoblasts into brown adipocytes via an NF-κB/YY1/miR-133 axis and NF-κB/YY1/BMP-7 axis. Cell Death Differ. 2017;24:2077-2088.  [PubMed]  [DOI]
69.  Fehér E, Pénzes L. Effect of an antioxidant compound (2-mercaptoethanol) on the nerve terminals of the aging small intestine. Exp Gerontol. 1990;25:135-140.  [PubMed]  [DOI]
70.  Patel PA, Chaudhary SS, Puri G, Singh VK, Odedara AB. Effects of β-mercaptoethanol on in vitro maturation and glutathione level of buffalo oocytes. Vet World. 2015;8:213-216.  [PubMed]  [DOI]
71.  Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 2009;32:591-601.  [PubMed]  [DOI]
72.  Wang Z, Tsai LK, Munasinghe J, Leng Y, Fessler EB, Chibane F, Leeds P, Chuang DM. Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke. Stroke. 2012;43:2430-2436.  [PubMed]  [DOI]
73.  Kim AJ, Shi Y, Austin RC, Werstuck GH. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J Cell Sci. 2005;118:89-99.  [PubMed]  [DOI]
74.  Gul H, Marquez-Curtis LA, Jahroudi N, Lo J, Turner AR, Janowska-Wieczorek A. Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling. Stem Cells Dev. 2009;18:831-838.  [PubMed]  [DOI]
75.  Okubo T, Hayashi D, Yaguchi T, Fujita Y, Sakaue M, Suzuki T, Tsukamoto A, Murayama O, Lynch J, Miyazaki Y. Differentiation of rat adipose tissue-derived stem cells into neuron-like cells by valproic acid, a histone deacetylase inhibitor. Exp Anim. 2016;65:45-51.  [PubMed]  [DOI]
76.  Hashemzadeh MA, Seyedi Z, Rafiei S, Hassanzadeh-Moghaddam M, Edalatmanesh MA. Chemokine receptor’s expression in human adipose derived mesenchymal stem cells primed with valproic acid. Comp Clin Pathol. 2017;26:115-120.  [PubMed]  [DOI]
77.  Silverman LR, Mufti GJ. Methylation inhibitor therapy in the treatment of myelodysplastic syndrome. Nat Clin Pract Oncol. 2005;2 Suppl 1:S12-S23.  [PubMed]  [DOI]
78.  Taylor SM, Jones PA. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell. 1979;17:771-779.  [PubMed]  [DOI]
79.  Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell. 1980;20:85-93.  [PubMed]  [DOI]
80.  Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol. 2003;183:355-366.  [PubMed]  [DOI]
81.  Long JL, Zuk P, Berke GS, Chhetri DK. Epithelial differentiation of adipose-derived stem cells for laryngeal tissue engineering. Laryngoscope. 2010;120:125-131.  [PubMed]  [DOI]
82.  Cheng NC, Wang S, Young TH. The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities. Biomaterials. 2012;33:1748-1758.  [PubMed]  [DOI]
83.  Hsueh YY, Chiang YL, Wu CC, Lin SC. Spheroid formation and neural induction in human adipose-derived stem cells on a chitosan-coated surface. Cells Tissues Organs. 2012;196:117-128.  [PubMed]  [DOI]
84.  Gao S, Zhao P, Lin C, Sun Y, Wang Y, Zhou Z, Yang D, Wang X, Xu H, Zhou F. Differentiation of human adipose-derived stem cells into neuron-like cells which are compatible with photocurable three-dimensional scaffolds. Tissue Eng Part A. 2014;20:1271-1284.  [PubMed]  [DOI]
85.  Wei Y, Gong K, Zheng Z, Wang A, Ao Q, Gong Y, Zhang X. Chitosan/silk fibroin-based tissue-engineered graft seeded with adipose-derived stem cells enhances nerve regeneration in a rat model. J Mater Sci Mater Med. 2011;22:1947-1964.  [PubMed]  [DOI]
86.  Georgiou M, Golding JP, Loughlin AJ, Kingham PJ, Phillips JB. Engineered neural tissue with aligned, differentiated adipose-derived stem cells promotes peripheral nerve regeneration across a critical sized defect in rat sciatic nerve. Biomaterials. 2015;37:242-251.  [PubMed]  [DOI]
87.  Ferrero-Gutierrez A, Menendez-Menendez Y, Alvarez-Viejo M, Meana A, Otero J. New serum-derived albumin scaffold seeded with adipose-derived stem cells and olfactory ensheathing cells used to treat spinal cord injured rats. Histol Histopathol. 2013;28:89-100.  [PubMed]  [DOI]
88.  Park SS, Lee YJ, Lee SH, Lee D, Choi K, Kim WH, Kweon OK, Han HJ. Functional recovery after spinal cord injury in dogs treated with a combination of Matrigel and neural-induced adipose-derived mesenchymal Stem cells. Cytotherapy. 2012;14:584-597.  [PubMed]  [DOI]
89.  Razavi S, Khosravizadeh Z, Bahramian H, Kazemi M. Time-Dependent Effect of Encapsulating Alginate Hydrogel on Neurogenic Potential. Cell J. 2015;17:304-311.  [PubMed]  [DOI]
90.  Khosravizadeh Z, Razavi S, Bahramian H, Kazemi M. The beneficial effect of encapsulated human adipose-derived stem cells in alginate hydrogel on neural differentiation. J Biomed Mater Res B Appl Biomater. 2014;102:749-755.  [PubMed]  [DOI]
91.  Kim TH, Shah S, Yang L, Yin PT, Hossain MK, Conley B, Choi JW, Lee KB. Controlling differentiation of adipose-derived stem cells using combinatorial graphene hybrid-pattern arrays. ACS Nano. 2015;9:3780-3790.  [PubMed]  [DOI]
92.  Jung AR, Kim RY, Kim HW, Shrestha KR, Jeon SH, Cha KJ, Park YH, Kim DS, Lee JY. Nanoengineered Polystyrene Surfaces with Nanopore Array Pattern Alters Cytoskeleton Organization and Enhances Induction of Neural Differentiation of Human Adipose-Derived Stem Cells. Tissue Eng Part A. 2015;21:2115-2124.  [PubMed]  [DOI]
93.  Huang J, Hu X, Lu L, Ye Z, Zhang Q, Luo Z. Electrical regulation of Schwann cells using conductive polypyrrole/chitosan polymers. J Biomed Mater Res A. 2010;93:164-174.  [PubMed]  [DOI]
94.  Qi F, Wang Y, Ma T, Zhu S, Zeng W, Hu X, Liu Z, Huang J, Luo Z. Electrical regulation of olfactory ensheathing cells using conductive polypyrrole/chitosan polymers. Biomaterials. 2013;34:1799-1809.  [PubMed]  [DOI]
95.  Matsumoto M, Imura T, Fukazawa T, Sun Y, Takeda M, Kajiume T, Kawahara Y, Yuge L. Electrical stimulation enhances neurogenin2 expression through β-catenin signaling pathway of mouse bone marrow stromal cells and intensifies the effect of cell transplantation on brain injury. Neurosci Lett. 2013;533:71-76.  [PubMed]  [DOI]
96.  Yang Y, Ma T, Ge J, Quan X, Yang L, Zhu S, Huang L, Liu Z, Liu L, Geng D. Facilitated Neural Differentiation of Adipose Tissue-Derived Stem Cells by Electrical Stimulation and Nurr-1 Gene Transduction. Cell Transplant. 2016;25:1177-1191.  [PubMed]  [DOI]
97.  Mariggiò MA, Fanò-Illic G. The effects of simulated microgravity on the human nervous system: The proposal of a three-dimensional glia–neuron co-culture cell model. Sci Proc. 2015;2:e892.  [PubMed]  [DOI]
98.  Genchi GG, Cialdai F, Monici M, Mazzolai B, Mattoli V, Ciofani G. Hypergravity stimulation enhances PC12 neuron-like cell differentiation. Biomed Res Int. 2015;2015:748121.  [PubMed]  [DOI]
99.  Shinde V, Brungs S, Henry M, Wegener L, Nemade H, Rotshteyn T, Acharya A, Baumstark-Khan C, Hellweg CE, Hescheler J. Simulated Microgravity Modulates Differentiation Processes of Embryonic Stem Cells. Cell Physiol Biochem. 2016;38:1483-1499.  [PubMed]  [DOI]
100.  Zarrinpour V, Hajebrahimi Z, Jafarinia M. Expression pattern of neurotrophins and their receptors during neuronal differentiation of adipose-derived stem cells in simulated microgravity condition. Iran J Basic Med Sci. 2017;20:178-186.  [PubMed]  [DOI]